Meropenem
Links shared publicly online about this topic
No Interaction Between Valproate and Meropenem in a Cirrhotic Patient (September)
theannals.com — “No Interaction Between Valproate and Meropenem in a Cirrhotic Patient (September)” View full resource at theannals.com
Most Recently Shared on August 3, 2011 at 11:09 am By:
No Interaction Between Valproate and Meropenem in a Cirrhotic Patient (September): http://bit.ly/nepjFa
Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.)
medicalnewstoday.com — “Hospira, Inc. (NYSE: HSP), the world leader in generic injectable pharmaceuticals, announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V” View full resource at medicalnewstoday.com
Most Recently Shared on June 24, 2010 at 1:07 pm By:
MNT Infect Diseases Health News
Hospira Receives FDA Approval For Meropenem For Injection, USP (I.V.) http://mnt.to/3Fhm #viruses #bacteria
APP to launch Meropenem, Cilastatin and Imipenem in the U.S.
news-medical.net — “APP Pharmaceuticals, Inc., a Fresenius Kabi Company, announced today that it will launch both Imipenem and Cilastatin for Injection, USP and Meropenem for Injection, USP in the United States. APP will begin shipping Meropenem for Injection the week of February 13, 2012 with Imipenem and Cilastatin for Injection scheduled to ship in the next three to five weeks.” View full resource at news-medical.net
Most Recently Shared on February 8, 2012 at 12:36 pm By:
News-Medical.Net Health News and Oncology
Oncology News: APP to launch Meropenem, Cilastatin and Imipenem in the U.S.: APP Pharmaceuticals, Inc., a Fresen... http://t.co/IRZI4tqC
FDA approves Hospira's meropenem for injection, USP (I.V.)
news-medical.net — “Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced it has received U.S. Food and Drug Administration (FDA) approval for meropenem for injection, USP (I.V.) 500 mg and 1 g vials. The medication, a carbapenem that belongs to the beta-lactam class of antibiotics, is a generic version of AstraZeneca's Merrem® I.V. Sales of the name-brand product in the United States were approximately $200 million in 2009.” View full resource at news-medical.net
Most Recently Shared on June 23, 2010 at 9:30 am By:
News-Medical.Net Health News and Oncology
Oncology News: FDA approves Hospira's meropenem for injection, USP (I.V.): Hospira, Inc., the world leader in gene... http://bit.ly/9hZfEV
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient
theannals.com — “TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient” View full resource at theannals.com
Most Recently Shared on July 21, 2011 at 7:15 pm By:
TDM-Guided Therapy with Daptomycin and Meropenem in a Morbidly Obese, Critically Ill Patient: OBJECTIVE: To desc... http://bit.ly/pRvNCd
Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy - Ameen - 2011 - International Journal of Dermatology - Wiley Online Library
onlinelibrary.wiley.com — “Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy - Ameen - 2011 - International Journal of Dermatology - Wiley Online Library” View full resource at onlinelibrary.wiley.com
Most Recently Shared on March 19, 2011 at 6:53 am By:
Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy: Conclusion  M... http://bit.ly/i7140B
Gastroenterology Article | Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections
mdlinx.com — “Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections” View full resource at mdlinx.com
Most Recently Shared on September 21, 2011 at 9:40 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Comp... http://t.co/CaYlTC2E #GI
Arch Neurol -- Abstract: Continuous Epileptiform Discharges in Patients Treated With Cefepime or Meropenem, October 2011, Naeije et al. 68 (10): 1303
archneur.ama-assn.org — “Archives of Neurology, a monthly professional medical journal published by the American Medical Association, publishes original, peer-reviewed scientific research on the nervous system” View full resource at archneur.ama-assn.org
Most Recently Shared on October 18, 2011 at 2:41 pm By:
Edgar Avalos, MD Neurology and Health Group
Continuous epileptiform discharges in patients treated with cefepime or meropenem http://t.co/amczkhUP
Gastro Medical News about Whipple Disease
mdlinx.com — “Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease” View full resource at mdlinx.com
Most Recently Shared on February 3, 2010 at 12:03 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
GI: Efficacy of Ceftriaxone or Meropenem as Initial Therapies in Whipple's Disease: Gastroenterology http://bit.ly/9c7qha
Infectious Dis. Medical News about Klebsiella pneumoniae
mdlinx.com — “Characteristics of Meropenem Heteroresistance in KPC Carbapenemase-Producing Klebsiella pneumoniae” View full resource at mdlinx.com
Most Recently Shared on June 8, 2010 at 3:04 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Characteristics of Meropenem Heteroresistance in KPC Carbapenemase-Producing Klebsiella pneumoniae: Journal of ... http://bit.ly/9H2Ouu #ID
Infectious Disease Article | Nocardia
mdlinx.com — “Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy” View full resource at mdlinx.com
Most Recently Shared on March 23, 2011 at 4:44 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Successful treatment of Nocardia actinomycetoma with meropenem and amikacin combination therapy: Internation... http://bit.ly/eNvMN8 #ID
Infectious Disease Article | Pneumonia, Ventilator-Associated
mdlinx.com — “Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia” View full resource at mdlinx.com
Most Recently Shared on March 30, 2011 at 2:44 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Penetration of Meropenem into Epithelial Lining Fluid of Patients with Ventilator-Associated Pneumonia: Anti... http://bit.ly/iizfYs #ID
Infectious Dis. Medical News about Pseudomonas aeruginosa
mdlinx.com — “The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill Rate and Resistance Suppression” View full resource at mdlinx.com
Most Recently Shared on May 27, 2010 at 7:16 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
The Combination of Meropenem and Levofloxacin Is Synergistic with Respect to both Pseudomonas aeruginosa Kill R... http://bit.ly/aAGCNG #ID
Infectious Disease Article | Klebsiella pneumoniae
mdlinx.com — “Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapenemase-producing Klebsiella pneumoniae” View full resource at mdlinx.com
Most Recently Shared on July 30, 2011 at 4:20 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Detection of synergy using the combination of polymyxin B with either meropenem or rifampin against carbapen... http://bit.ly/pVCYng #ID
Infectious Disease Article | Escherichia coli
mdlinx.com — “Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum beta-lactamase–producing Klebsiella pneumoniae and Escherichia coli” View full resource at mdlinx.com
Most Recently Shared on August 23, 2011 at 2:25 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extended-spectrum beta-... http://t.co/Ihw5bLM #ID
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
The Annals
The Annals of Pharmacotherapy is a peer-reviewed medical journal advancing drug therapy by publishing evidence-based pharmacy research and clinical reviews.
-
MNT Infect Diseases
The latest infectious diseases / bacteria / viruses news published daily. Articles from research centers, universities and prestigious journals.
-
News-Medical.Net
Stay up to date with the latest Oncology news and research via News-Medical.Net
Advertisement
